| Period Ending | Dec 30, 2012 | Dec 30, 2011 | Dec 30, 2010 |
|---|
|
Total Revenue
|
14,954
|
2,099
|
595
| | Cost of Revenue |
-
|
-
|
-
| | |
Gross Profit
|
14,954
|
2,099
|
595
| |
|
Operating Expenses |
|
Research Development | 37,347 | 17,346 | 9,866 |
|
Selling General and Administrative | 17,396 | 9,268 | 3,852 |
|
Non Recurring |
-
|
-
|
-
|
|
Others | 3,232 | 504 |
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(43,021)
|
(25,019)
|
(13,123)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
| (259) | 2,295 |
|
Earnings Before Interest And Taxes | (42,949) | (25,306) | (10,824) |
|
Interest Expense |
-
|
-
|
-
|
|
Income Before Tax | (42,949) | (25,306) | (10,824) |
|
Income Tax Expense |
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (42,949) | (25,306) | (10,824) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(42,949)
|
(25,306)
|
(10,824)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(42,949)
|
(25,306)
|
(10,824)
|
|